Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jul 13;109(1):245–255. doi: 10.3324/haematol.2023.283251

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright© 2024 Ferrata Storti Foundation

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

PMC Copyright notice

Figure 1. — Kaplan-Meier curves for all 200 patients with relapsed or refractory multiple myeloma treated with the elotuzumab, pomalidomide and dexamethasone triple regimen. (A) Kaplan-Meier curve of progression-free survival. (B) Kaplan-Meier curve of overall survival. (C) Kaplan-Meier curve of time to next treatment.